-+ 0.00%
-+ 0.00%
-+ 0.00%

LUNDBECK ANNOUNCES LAST PATIENT RANDOMIZED IN DEEP SEA, A PHASE III TRIAL OF BEXICASERIN IN DRAVET SYNDROME

Reuters·09/15/2026 07:26:48

Please log in to view news